Drontal Dog Tasty Bone Wormer Tablets

Uses
For the treatment of mixed infections by the following species of nematodes and cestodes in dogs:
Roundworms
• Ascarids (adult and late immature forms): Toxocara canis, Toxascaris leonina
• Hookworms (adults): Uncinaria stenocephala, Ancylostoma caninum
• Whipworms (adults): Trichuris vulpis
  Tapeworms (adult and immature forms)
• Echinococcus granulosus, Echinococcus multilocularis, Dipylidium caninum, Taenia spp.

Dosage and administration
For oral administration only.
Dosage: For treatment of dogs administer 1 Drontal Dog Tasty Bone 150/144/50 mg tablets per 10 kg body weight (15 mg febantel, 14.4 mg pyrantel embonate and 5 mg praziquantel/kg body weight) or 1 Drontal Dog Tasty Bone XL 525/504/175 mg tablets per 35 kg body weight (15 mg febantel, 14.4 mg pyrantel embonate and 5 mg praziquantel/kg body weight). 

Dosages are as follows
Drontal Tasty Bone Tablets
Body weight (kg)
Tablet quantity
  2 -    5           ½
>5 -   10         1
>10 - 5           1 ½
>15 - 20         2

Administration and Duration of Treatment:
The tablets are flavoured and studies have shown that they are palatable and are taken voluntarily by the majority (88%) of dogs tested.
The tablets can be administered with or without food. Access to normal diet does not need to be limited before or after treatment.
Tablets should be given as a single administration.
The advice of a veterinarian should be sought regarding the need for and frequency of repeat treatment.
Drontal Dog Tasty Bone 150/144/50 mg tablets: Not for use in dogs weighing less than 2 kg.

Use During Pregnancy and Lactation
Teratogenic effects attributed to high doses of febantel administered during early pregnancy have been reported in rats, sheep and dogs.
The safety of the product has not been investigated during the 1st and 2nd third of pregnancy. Do not use in pregnant dogs during the 1st and 2nd third of pregnancy (see Contra-Indications, Warnings etc).
A single treatment during the last third of pregnancy or during lactation has been demonstrated safe.

Contra-indications, warnings, etc
Do not use in case of hypersensitivity to the active substances or to any of the excipients.
Do not use during the 1st and 2nd third of pregnancy.
Fleas serve as intermediate hosts for one common type of tapeworm - Dipylidium caninum. Tapeworm infestation is certain to re-occur unless control of intermediate hosts such as fleas, mice etc. is undertaken.
Parasite resistance to any particular class of anthelmintic may develop following frequent, repeated use of an anthelmintic of that class.
To minimise the risk of re-infestation and new infestation, excreta should be collected and properly disposed of for 24 hours following treatment.
In very rare cases mild and transient digestive tract disorders (e.g. vomiting) may occur.
The frequency of adverse reactions is defined using the following convention:
- very rare (less than 1 animal in 10,000 animals, including isolated reports).
The anthelmintic effects of this product and piperazine containing products may be antagonised when the two drugs are used together.
10 times the recommended dose of the product was tolerated without signs of adverse reactions in dogs and pups.
Since it contains praziquantel, the product is effective against Echinococcus spp. which do not occur in all EU member states but are becoming more common in some. Echinococcosis represents a hazard for humans. As echinococcosis is a notifiable disease to the World Organisation for Animal Health (OIE), specific guidelines on the treatment and follow-up, and on the safeguard of persons, need to be obtained from the relevant competent authority.
User Safety
In case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician.
In the interests of good hygiene, persons administering the product directly to a dog or by adding it to the dog’s food should wash their hands afterwards.
Environmental Safety
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal product should be disposed of in accordance with local requirements.

Pharmaceutical precautions
This veterinary medicinal product does not require any special storage conditions.
Shelf life of the veterinary medicinal product as packaged for sale: 3 years
Shelf life of half-tablets: 7 days
Drontal Dog Tasty Bone 150/144/50 mg tablets: After opening the blister, remaining half-tablets should be wrapped in aluminium foil and returned to the open blister.

Legal category: NFA-VPS

Marketing Authorisation Number
Drontal Dog Tasty Bone 150/144/50mg Tablets
Vm 00010/4187

GTIN
GTIN description:Drontal Dog Tasty Bone 150/144/50 mg Tablets (2 Tablets)
GTIN:04007221036197